TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/21/18 18:08 | 12/21/18 | SVRA | Savara Inc | DE | Health | Drug | Pharmaceutical Preparations | Neville Robert N | TX | DO | CEO | P | 150 | 6.38 | 0 | 24 | 5 | 498 | D | ||||||||||||||
6/12/18 20:26 | 6/8/18 | SVRA | Savara Inc | DE | Health | Drug | Pharmaceutical Preparations | Neville Robert N | TX | DO | CEO | S.dm | -217 | 12.09 | 0 | -18 | -4 | 475 | D | ||||||||||||||
6/12/18 20:26 | 6/11/18 | SVRA | Savara Inc | DE | Health | Drug | Pharmaceutical Preparations | Neville Robert N | TX | DO | CEO | M.d | 60 | 0.6500 | 0 | 92 | 24 | 475 | D | ||||||||||||||
2/20/18 06:09 | 2/15/18 | SVRA | Savara Inc | DE | Health | Drug | Pharmaceutical Preparations | Neville Robert N | TX | DO | CEO | S | -323 | 12.93 | 0 | -25 | -6 | 405 | D | ||||||||||||||
6/9/17 10:38 | 6/7/17 | SVRA | Savara Inc | DE | Health | Drug | Pharmaceutical Preparations | Neville Robert N | TX | DO | CEO | P | 248 | 4.75 | 0 | 52 | 14 | 430 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |